TL;DR
A commonly used tirzepatide titration schedule starts at 2.5 mg once weekly for four weeks, followed by 5 mg if prescribed. Later increases are typically made in 2.5 mg steps after at least four weeks at the current dose. Four weeks is the earliest point to consider an increase, not a deadline. We recommend confirming every change against the current product label and prescription.
Tirzepatide titration schedule by week
For products that follow the usual labeled pattern, treatment begins at 2.5 mg once weekly. A prescriber may move the dose to 5 mg after four weeks, then consider later increases in 2.5 mg steps after at least four weeks at each dose.
This schedule shows the earliest possible progression. It does not mean every patient should increase on those dates or use every available strength.
Week-by-week tirzepatide dose table
| Week | Earliest scheduled dose |
|---|---|
| 1–4 | 2.5 mg |
| 5–8 | 5 mg, if prescribed |
| 9–12 | 7.5 mg, if prescribed |
| 13–16 | 10 mg, if prescribed |
| 17–20 | 12.5 mg, if prescribed |
| 21 onward | 15 mg, if prescribed |
A prescriber may keep the dose unchanged, delay an increase, lower it, pause treatment, or stop it. The decision can depend on clinical response, side effects, health history, other medicines, the prescribed product, and the treatment indication.
Extra caution is needed with compounded vials because concentrations and instructions can differ. Never infer syringe units from a milligram dose without checking the pharmacy label.
Earliest week each dose can begin
Under uninterrupted escalation using the pattern above:
- 7.5 mg may begin in week 9.
- 10 mg may begin in week 13.
- 12.5 mg may begin in week 17.
- 15 mg may begin in week 21.
These are planning dates, not dosing instructions. Our goal is not to move every patient to the highest available strength. It is to support a prescribed dose that offers clinical benefit with acceptable tolerability.
How often should you titrate tirzepatide?
The commonly used labeled schedule allows an increase only after at least four weeks at the current dose. A prescriber can also continue the same dose for longer.
Four weeks is a minimum, not a deadline
Completing four weeks means an increase may be considered. It does not make the increase automatic.
We recommend reviewing:
- Clinical response
- Current side effects
- Treatment indication
- Prescribed product
- Other medicines and health conditions
A calendar reminder should prompt a prescription check, not an unsupervised dose change.
Can you increase tirzepatide after three weeks?
The usual labeled schedule does not support a self-directed increase after three weeks. Patients should continue the prescribed dose and contact their prescribing team if response or side effects are causing concern.
Do not inject early, stack doses, or use another patient’s plan.
What to expect when increasing tirzepatide from 2.5 mg to 5 mg
The 2.5 mg starting dose is intended to introduce treatment gradually. Depending on the product and indication, it may not be considered a maintenance dose.
Gastrointestinal effects associated with tirzepatide can include:
- Nausea
- Diarrhea
- Vomiting
- Constipation
- Abdominal discomfort
- Indigestion
Experiences vary, and stronger side effects do not mean the medicine is working better. We suggest recording meals, fluid intake, bowel changes, vomiting, abdominal pain, and when symptoms began.
When to hold the planned increase and call the prescriber
Contact the prescribing team if symptoms persist, worsen, or make eating and drinking difficult. A clinician may decide to keep the current dose in place longer.
Do not increase solely because the next calendar block has begun.
Symptoms that need prompt medical review
Seek prompt medical advice for severe or persistent abdominal pain, particularly with vomiting. Signs of dehydration, a severe allergic reaction, or possible gallbladder trouble also warrant medical review.
Use urgent or emergency care for severe symptoms. An online schedule cannot diagnose their cause or determine whether treatment should continue.
Do you need to reach 15 mg?
No. The highest available dose is not the target for every patient.
A maintenance dose depends on the product, indication, response, and tolerability. Trial averages cannot predict an individual result or justify self-escalation.
Available strengths are options rather than compulsory steps. Similar caution applies when comparing tirzepatide with medicines still being researched. Our review of retatrutide versus tirzepatide explains why early evidence should not replace current prescribing guidance.
Starting doses and maintenance doses serve different purposes
A starting dose helps introduce the medicine gradually. Maintenance options may differ by brand and approved use, while some strengths may mainly support escalation.
Check the current labeling and prescription rather than applying one product’s schedule to another. New oral or injectable medicines can follow different plans, as discussed in our guide to orforglipron’s FDA status, dosing, and availability.
When staying at the current dose may make sense
A clinician may recommend staying at the current prescribed dose when response is adequate and side effects are manageable. Feeling well does not create an automatic need to increase.
We do not promise a particular result at any dose. The full clinical response matters.
GLP-1 titration calculator: calculate dates, not doses
A GLP-1 titration calculator can turn a start date and injection day into estimated dose-block dates. It should identify only the earliest possible escalation date and make clear that a prescriber may delay or decline the increase.
A calculator should never choose a dose, shorten an interval, or interpret symptoms.
Inputs for a tirzepatide date calculator
Useful inputs may include:
- First injection date
- Usual injection day
- Current prescribed dose
- Weekly doses completed at that strength
- Prescriber-approved next dose
A tirzepatide calculator should not be reused for other medicines, including products covered in our review of cagrilintide evidence, safety, and access.
What a calculator cannot decide
No calculator can assess vomiting, hydration, abdominal pain, pregnancy plans, other medicines, or treatment goals. It cannot replace the product label, pharmacy instructions, or prescribing team.
Tirzepatide milligrams versus syringe units
Milligrams measure the amount of drug. Syringe units measure liquid volume.
With compounded vials, concentration may vary by pharmacy and prescription. That means a universal conversion chart could produce the wrong dose.
Why concentration controls the conversion
The basic calculation is:
Volume in mL = prescribed milligrams ÷ concentration in mg/mL
For syringes marked in units, the volume must then be matched to the syringe’s scale. The milligram dose alone is not enough to determine the correct unit marking.
These calculations are educational, not personal dosing instructions.
How Temi patients should confirm a syringe dose
Temi patients should use the milligram dose, concentration, and syringe volume shown in their current instructions. If any value is missing or unclear, we recommend asking the Temi prescribing team or dispensing pharmacy before injecting.
Never copy a unit amount from social media, another vial, or an old prescription.
Missed doses, schedule changes, and delayed increases
Missed-dose instructions can depend on the exact product. Some tirzepatide labeling provides a limited window in which a missed dose may be taken; after that window, the dose is generally skipped rather than doubled.
Check the current product instructions or contact the prescribing team. A delayed dose may also move later titration dates.
Changing the weekly injection day
Product labeling may allow the weekly injection day to change when enough time separates the doses. Confirm the required interval for the exact product and prescription before changing days.
We do not recommend estimating the interval or moving injections closer together without approval.
How a held dose changes the calendar
Recalculate any proposed increase from the actual treatment record and the prescriber’s instructions. Do not assume an interrupted course should restart at the same or a higher dose.
After several missed doses or a longer interruption, ask the prescriber how to resume.
How to titrate down or stop tirzepatide
There is no single reduction schedule suitable for every patient. Depending on the reason, a clinician may recommend a lower dose, a pause, or stopping treatment.
Do not simply reverse the escalation table. Follow-up may need to cover appetite, weight, blood glucose when relevant, side effects, and other medicines.
Reasons to contact the prescriber before reducing or stopping
Speak with the prescribing team about:
- Persistent side effects
- Pregnancy or planned pregnancy
- Planned surgery
- A new diagnosis or medicine
- Low blood glucose risk with other diabetes treatment
- Cost, supply, or access problems
A tirzepatide change can affect the wider treatment plan.
Questions to ask for a written plan
Ask:
- Which dose should I take next?
- On what date should I take it?
- Does another medicine need to change?
- Which symptoms require urgent care?
- What should I do if the next dose is unavailable?
Keep the written plan with the medication instructions.
Tirzepatide titration questions
How often should I titrate tirzepatide?
An increase may be considered after at least four weeks at the current dose, but the prescriber may wait longer. Use the week-by-week calendar to identify a possible date, not to approve a change.
Can I titrate tirzepatide faster?
Do not shorten the prescribed interval without direct clinical instructions. Review the minimum four-week rule.
What if my weight has not changed after three weeks?
Weight alone should not determine the next dose. Discuss overall response and tolerability with the prescriber before making changes.
Do I have to increase if I feel fine?
No. See when staying at the current dose may make sense.
Can I convert milligrams to syringe units?
Not without the exact concentration and syringe type. Read why concentration controls the conversion and contact the prescribing team or pharmacy if anything is unclear.
FAQ
What is the usual tirzepatide dosing schedule?
A common labeled pattern starts at 2.5 mg once weekly, followed by 5 mg if prescribed. Later increases may occur in 2.5 mg steps after at least four weeks at each dose.
Is an increase required every four weeks?
No. Four weeks is generally the earliest consideration point. A prescriber may continue the same dose longer.
Do I need to reach 15 mg?
No. The appropriate maintenance dose depends on the product, indication, response, and tolerability.
How do I titrate down from tirzepatide?
There is no universal schedule. Ask the prescriber for written instructions rather than reversing the escalation table.
What should I do after a missed dose?
Follow the instructions for the exact product. Do not double the next dose, and contact the prescribing team after several missed doses or a long interruption.
Confirm your next dose
Use the current prescription, pharmacy label, and actual injection dates before changing treatment. If the dose, date, concentration, or syringe volume is unclear, contact Temi for a clinician review before injecting.
